ELUSYS THERAPEUTICS

Elusys Therapeutics is a privately-held biopharmaceutical company focused on the development of antibody-based therapies for the treatment of infectious disease. The Company has pioneered the development of a rapid injection, anti-toxin antibody, Anthim:registered:, for the prophylaxis and treatment of anthrax disease following a biowarfare attack. Anthim has consistently demonstrated significant efficacy in multiple non-clinical animal studies and has been successfully evaluated in two clinical safety trials.

ELUSYS THERAPEUTICS

Industry:

Biotechnology

Founded:

1998-01-01

Address:

Pine Brook, New Jersey, United States

Country:

United States

Website Url:

http://www.elusys.com

Total Employee:

11+

Status:

Active

Contact:

9738080322

Email Addresses:

[email protected]

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins

Similar Organizations

lead-therapeutics-logo

Current Advisors List

not_available_image

Frank Young Board of Director @ Elusys Therapeutics
Board_member

Current Employees Featured

not_available_image

Elizabeth Posillico
Elizabeth Posillico President and Chief Executive Officer @ Elusys Therapeutics
President and Chief Executive Officer
2005-01-01

robin-l-conrad_image

Robin L Conrad
Robin L Conrad Vice President @ Elusys Therapeutics
Vice President
2013-04-01

Founder

jeff-wolf_image

Jeff Wolf

Official Site Inspections

http://www.elusys.com

Host Informations
Whois Informations

Loading ...